(Date:12/2/2009)... study results strengthen the evidence that people...ave an increased risk for developing colorectal ca... , "This provides one more reason not to smoke,...or Michael J. Thun, M.D., M.S., vice president eme...he American Cancer Society. "Colorectal cancer sho...
(Date:12/2/2009)...xposure to secondhand smoke for a prolonged period...k of breast cancer, even in women who never smoked...her exposure to side-stream smoke could increase r...aid Peggy Reynolds, Ph.D., senior research scienti...eley office. "While no single epidemiologic study ...
(Date:12/2/2009)...the University of Georgia College of Veterinary Me...at could open new avenues for treating Ichthyophth...celled protozoan parasite that commonly attacks fr...quencing, researchers found that Ich harbors two a...roides, which are usually found free-living, and R...
Breaking Biology News(10 mins):Cigarette smoking increases colorectal cancer risk 2Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 3California Cryobank Introduces Celebrity Look a Likes for Sperm Donors 52899 1California Cryobank Introduces Celebrity Look a Likes for Sperm Donors 52899 2QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System 52896 1QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System 52896 2QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System 52896 3QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System 52896 4QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System 52896 5QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System 52896 6QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System 52896 7Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 52892 1Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 52892 2Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 52892 3Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 52892 4Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 52892 5Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 52892 6Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 52892 7Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 52892 8(Date:12/2/2009)... , JERUSALEM, Israel, December 2 /P...ility study evaluating the preclinical (animal stu...which combines technology from Weill,Cornell Medic...otential to,treat inherited anemias such as Cooley...series of technologies to expand, ex vivo,populat...
(Date:12/2/2009)... , QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ ... (the "Company"), a global biopharmaceutical compa...y announced that the U.S. Food and Drug Administra...the Company,s PI3K/Akt pathway inhibitor compound,...sed/refractory multiple myeloma. Keryx Biopharmace...
(Date:12/1/2009)... Dr. Kerry Solomon announced t...has launched his redesigned website at www.DrKerr...ulting Group. Dr. Solomon is a proven LASIK, lens... professionally recognized for his substantial con... He is a member of Trusted LASIK Surgeons, which ...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Repo...report is available in its catalogue: ,, Emerg...ket dynamics and the changing healthcare and regul...com/p0165658/Emerging-Clinical-Trial-Locations---E...lthcare-and-regulatory-environment.html ,, Ove...
Breaking Biology Technology:Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8...rsity of Technology (TU/e) have developed an entir...r the first time they used mechanical forces to co...tal concepts in chemistry. This allowed them to in...his discovery paves the way to developing material...nce of mechanical tension. The results of their re...
...er Life Sciences, Inc. (Nasdaq: CALP ) today ann...s will be held on June 2, 2009, at 10:00 a.m. loca...pkinton, Massachusetts. The record date for Calip...s April 16, 2009. , , About Caliper Life Sci...er of cutting-edge technologies enabling researche...
...pril 6 Today, Pepscan reports,that it has achieve...of its,CLIPS-based synthetic peptide immunogen tec...e ligand binding-site on CXCR7 it has induced func... GPCR target CXCR7. CXCR7 is novel,therapeutic tar..., "We are proud and confident with achieving t...
Other Biology Technology:A molecular ripcord for chemical reactions 2Pepscan Achieves a Breakthrough With CLIPS Immunogen Technology: Synthetic Peptide Antigen is Able to Induce Fully Functional Antibodies Against a Formerly Intractable GPCR Target CXCR7 2Nitrite Colorimetric Assay Kit from Molecular Probes (Invitrogen)
Basement Membrane Extract - Phenol Red from R&D Systems
...x High Protein Concentration Basement Membrane Ext...o applications where higher protein concentrations...rength, and elevated levels of tumor augmentation....sistency and controlled protein concentrations to ...
mitochondrial proteins (human heart) for SDS-polyacrylamide gel electrophoresis from Molecular Probes (Invitrogen)
Biology Products: